Diablo Clinical Research, Inc. — Walnut Creek, California

Public research footprint of Diablo Clinical Research, Inc., compiled from the ClinicalTrials.gov public registry.

154

Registered studies

Active

Recruiting now

113

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Diabetes Mellitus, Type 2 · Influenza, Human · SARS-COV-2 Infection

Recently updated registry entries

NCT05929079 — A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have… (Completed)
NCT07011667 — A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose… (Active Not Recruiting)
NCT07720271 — AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Diablo Clinical Research, Inc.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.